ATE94056T1 - Verfahren zur herstellung einer nanoemulsion von oelpartikeln in einer waessrigen phase. - Google Patents

Verfahren zur herstellung einer nanoemulsion von oelpartikeln in einer waessrigen phase.

Info

Publication number
ATE94056T1
ATE94056T1 AT90810436T AT90810436T ATE94056T1 AT E94056 T1 ATE94056 T1 AT E94056T1 AT 90810436 T AT90810436 T AT 90810436T AT 90810436 T AT90810436 T AT 90810436T AT E94056 T1 ATE94056 T1 AT E94056T1
Authority
AT
Austria
Prior art keywords
nanoemulsion
aqueous phase
oil
emulsifier
alkyl
Prior art date
Application number
AT90810436T
Other languages
German (de)
English (en)
Inventor
Hans Georg Prof Dr Weder
Matthias Muetsch
Original Assignee
Weder Hans G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4232280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE94056(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Weder Hans G filed Critical Weder Hans G
Application granted granted Critical
Publication of ATE94056T1 publication Critical patent/ATE94056T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21—Emulsions characterized by droplet sizes below 1 micron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Colloid Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90810436T 1989-06-26 1990-06-15 Verfahren zur herstellung einer nanoemulsion von oelpartikeln in einer waessrigen phase. ATE94056T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2374/89A CH677886A5 (https=) 1989-06-26 1989-06-26
EP90810436A EP0406162B1 (de) 1989-06-26 1990-06-15 Verfahren zur Herstellung einer Nanoemulsion von Oelpartikeln in einer wässrigen Phase

Publications (1)

Publication Number Publication Date
ATE94056T1 true ATE94056T1 (de) 1993-09-15

Family

ID=4232280

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90810436T ATE94056T1 (de) 1989-06-26 1990-06-15 Verfahren zur herstellung einer nanoemulsion von oelpartikeln in einer waessrigen phase.

Country Status (7)

Country Link
US (1) US5152923A (https=)
EP (1) EP0406162B1 (https=)
JP (1) JPH0347527A (https=)
AT (1) ATE94056T1 (https=)
CA (1) CA2019710A1 (https=)
CH (1) CH677886A5 (https=)
DE (1) DE59002618D1 (https=)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679788B1 (fr) * 1991-08-02 1994-03-18 Thorel Jean Noel Structures d'emulsions polyphasiques autostabilisees.
US5304325A (en) * 1991-11-13 1994-04-19 Hemagen/Pfc Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
FR2687569B1 (fr) * 1992-02-21 1995-06-09 Oreal Composition cosmetique pour le maquillage des yeux, comprenant une microdispersion de cire.
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas
SE9301171D0 (sv) * 1993-04-07 1993-04-07 Ab Astra Pharmaceutical composition containing lipophilic drugs
US5492648A (en) * 1993-07-02 1996-02-20 Lau; John R. Organic oil stabilization techniques
FR2709666B1 (fr) * 1993-09-07 1995-10-13 Oreal Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
DE69528062T2 (de) * 1994-06-20 2003-04-30 Nippon Shinyaku Co., Ltd. Verfahren zum herstellen von emulsionen aus einem emulgator
EP0711557A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage
US5629021A (en) * 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
FR2742676B1 (fr) 1995-12-21 1998-02-06 Oreal Nanoemulsion transparente a base de tensioactifs silicones et utilisation en cosmetique ou en dermopharmacie
FR2742988B1 (fr) * 1996-01-03 1998-01-30 Oreal Composition aqueuse contenant des vesicules lipidiques non-ioniques et au moins un pigment non-enrobe disperse dans la phase aqueuse, procede de preparation, utilisations
EP0865792A1 (de) * 1997-03-17 1998-09-23 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Pharmazeutische Zusammensetzung mit Immunglobulinen zur topischen Anwendung
US5994414A (en) * 1997-04-28 1999-11-30 Avon Products, Inc. Water-thin emulsion formed by high pressure homogenization process
WO1998047464A1 (en) * 1997-04-18 1998-10-29 Avon Products, Inc. Water-thin emulsion formed by high pressure homogenization process
DE19745950A1 (de) * 1997-10-17 1999-04-22 Dds Drug Delivery Service Ges Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation
ATE372377T1 (de) * 1998-03-30 2007-09-15 Mibelle Ag Cosmetics Verwendung von nanoemulsionen zur bestimmung der biokompatibilität von lipophilen stoffen im zellkultur-test und dafür geeignete nanoemulsionen
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
TWI241915B (en) * 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
US7165624B1 (en) * 1998-05-15 2007-01-23 Grinnell Corporation Early suppression fast response fire protection sprinkler
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
ES2211151T3 (es) 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
DE19852245A1 (de) 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
FR2787326B1 (fr) † 1998-12-17 2001-01-26 Oreal Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
FR2788007B1 (fr) * 1999-01-05 2001-02-09 Oreal Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
DE60019239T3 (de) * 1999-12-09 2017-03-02 Dsm Ip Assets B.V. Fettlösliche Vitamine enthaltende Zusammensetzungen
FR2804015B1 (fr) 2000-01-21 2005-12-23 Oreal Nanoemulsion contenant des lipides amphiphiles et un polymere non ionique et utilisations
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7153516B2 (en) 2001-07-02 2006-12-26 Color Access, Inc. Ringing nanogel compositions
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US7763663B2 (en) * 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
DE10209860A1 (de) * 2002-03-06 2003-09-25 Hemofarm Konzern A D Hydrophobe Nanotropfen mit gebundenen Hämoglobinmolekülen in hydrophiler Phase enthaltene Emulsion als Blutersatzstoff
US20040115159A1 (en) * 2002-03-29 2004-06-17 Tadlock Charles C Novel nanoemulsions
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
DE10325767A1 (de) * 2003-06-05 2004-12-23 Beiersdorf Ag Verfahren zur Herstellung feindisperser, aber nicht transparenter Zubereitungen
JP2007520555A (ja) * 2004-02-05 2007-07-26 バクスター・インターナショナル・インコーポレイテッド 自己安定化剤の使用により調製された分散剤
DE102004049574A1 (de) * 2004-10-12 2006-04-20 Doris Dr. Barnikol-Keuten Arzneimittel und System zur perkutanen Arzneistoffverabreichung
CH697378B1 (de) * 2005-02-11 2008-09-15 Claudia Marcoli Vorrichtung zur Oberflächenbehandlung von Teilen mittels Nanoemulsionen sowie Verfahren zur Erzeugung und zur Anwendung von Nanoemulsionen.
BRPI0613631A8 (pt) * 2005-07-18 2017-12-26 Univ Massachusetts Lowell nanoemulsão e método,
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
BRPI0619134B8 (pt) 2005-12-01 2021-05-25 Univ Massachusetts Lowell nanoemulsão, composição farmacêutica, composição, métodos cosméticos para o tratamento de rugas, linhas faciais e/ou linhas do pescoço, e de retardar o início das rugas, linhas faciais e/ou linhas do pescoço, e, método de fabricação de uma nanoemulsão
SG10201607909WA (en) 2006-12-01 2016-11-29 Anterios Inc Peptide nanoparticles and uses therefor
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
WO2008102065A1 (fr) * 2007-02-14 2008-08-28 Commissariat A L'energie Atomique Emulsions fluorescentes pour l'imagerie optique
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
WO2008151022A2 (en) 2007-05-31 2008-12-11 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
AU2010210600B2 (en) 2009-02-06 2016-07-14 C3 Jian, Inc. Calcium-binding agents induce hair growth and/or nail growth
DE102009056871A1 (de) * 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
US20110229516A1 (en) * 2010-03-18 2011-09-22 The Clorox Company Adjuvant phase inversion concentrated nanoemulsion compositions
US8500104B2 (en) 2010-06-07 2013-08-06 James Richard Spears Pressurized liquid stream with dissolved gas
CA2877102C (en) 2011-06-29 2020-06-30 Avidas Pharmaceuticals Llc Topical formulations including lipid microcapsule delivery vehicles and their uses
AU2013235422B2 (en) 2012-03-19 2016-12-15 Buck Institute For Research On Aging APP specific BACE inhibitors (ASBIs) and uses thereof
US20140371283A1 (en) 2013-02-12 2014-12-18 Buck Institute For Research On Aging Hydantoins that modulate bace-mediated app processing
US11172675B2 (en) 2014-12-22 2021-11-16 Oro Agri Inc. Nano particulate delivery system
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
EP3565573B1 (en) 2017-01-05 2023-08-23 The Regents of The University of California Pac1 receptor agonists (maxcaps) and uses thereof
GB2584009B (en) 2017-08-28 2022-03-23 Revagenix Inc Aminoglycosides and uses thereof
US11583497B2 (en) * 2017-11-14 2023-02-21 The Schepens Eye Research Institute, Inc. Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
US11673907B2 (en) 2018-04-03 2023-06-13 Revagenix, Inc. Modular synthesis of aminoglycosides
US20200147032A1 (en) 2018-11-14 2020-05-14 Robert K. Prud'homme Dihydromyricetin hot melt extrusion formulations and methods for forming them
EP3914245A4 (en) 2019-01-22 2022-08-24 Aeovian Pharmaceuticals, Inc. MTORC-1 MODULATORS AND USES THEREOF
CN110639425B (zh) * 2019-10-22 2021-09-17 湖北文理学院 复合乳化剂的制备方法
IL315304A (en) 2022-03-04 2024-10-01 Revagenix Inc Broad spectrum aminoglycosides and uses thereof
WO2024208433A1 (en) * 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1249454B (de) * 1960-08-26 1967-09-07 Vitrum Apoteksvar Verfahren zur Herstellung intravenoes verabreichbarer Fettemulsionen
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
US4794000A (en) * 1987-01-08 1988-12-27 Synthetic Blood Corporation Coacervate-based oral delivery system for medically useful compositions
WO1988008301A1 (en) * 1987-04-22 1988-11-03 Baxter Travenol Laboratories, Inc. Lipid emulsion and method for intravenous infusion
US5021381A (en) * 1988-08-24 1991-06-04 The Goodyear Tire & Rubber Company Syndiotactic 1,2-polybutadiene latex

Also Published As

Publication number Publication date
EP0406162A3 (en) 1991-03-20
DE59002618D1 (de) 1993-10-14
EP0406162B1 (de) 1993-09-08
JPH0347527A (ja) 1991-02-28
CA2019710A1 (en) 1990-12-26
CH677886A5 (https=) 1991-07-15
US5152923A (en) 1992-10-06
EP0406162A2 (de) 1991-01-02

Similar Documents

Publication Publication Date Title
ATE94056T1 (de) Verfahren zur herstellung einer nanoemulsion von oelpartikeln in einer waessrigen phase.
US5294444A (en) Transparent or semi-transparent cosmetic composition
EP0278660B1 (en) Microemulsions
US4263284A (en) Hand cleaning composition
KR930000060B1 (ko) 고농도의 향로를 갖는 연속적 수성상의 향수 조성물
US4832858A (en) Water dispersible petroleum jelly compositions
WO1980001144A1 (en) Water soluble lecithin composition
KR890006212A (ko) 소르보하이드록삼산을 포함하는 광보호조성물
JP2002522372A (ja) 発泡性オイル製剤およびその使用方法
JPS61277607A (ja) 流動性パ−ル光沢濃縮物
EP0347844B1 (en) A translucent cosmetic emulsion
EP0158108A1 (en) Detergent composition
DE3861985D1 (de) Verfahren zur herstellung von trialkanolamindifettsaeureestern und deren verwendung.
PT90199A (pt) Processo para a preparacao de uma composicao anti-inflamatoria hidratante para a pele
US5342536A (en) Nail polish remover with gelatin
DE3689478D1 (de) Teilchenförmiges emulgierbares haarkonditioniermittel.
DK0673201T3 (da) Shortening-erstatning med reduceret fedtindhold til bageriprodukter
EP0084341B2 (en) Emulsion-type composition for external use
ATE85888T1 (de) Verfahren zur herstellung dispergierbarer kolloidaler systeme aus amphiphilen lipiden in form von liposomen in submikrongroesse.
DK0808154T3 (da) Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer
FR2706298B1 (fr) Composition cosmétique ou dermatologique sous forme d'une émulsion huile-dans-l'eau stable contenant au moins une huile végétale constituée d'au moins 40% de triglycérides d'acide linoléique.
DK0458600T3 (da) Kosmetisk emulsion
EP0771186A1 (en) Detergent composition
EP0062352A1 (en) Soap composition
JP2003055128A (ja) 透明化粧料組成物

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee